PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Penn study finds more effective approach against 'Achilles' heel' of ovarian cancer

2011-08-09
(Press-News.org) PHILADELPHIA - In a recent issue of Cancer Research, Daniel J. Powell, Jr., PhD, a research assistant professor of Pathology and Laboratory Medicine and Obstetrics and Gynecology at the Perelman School of Medicine at the University of Pennsylvania, showed for the first time that engineered human T cells can eradicate deadly human ovarian cancer in immune-deficient mice. Ovarian cancer is the most lethal reproductive cancer for women, with one-fifth of women diagnosed with advanced disease surviving five years. Nearly all ovarian cancers (90%) are characterized by their expression of a distinct cell-surface protein called alpha-folate receptor, which can be a target for engineered T cells.

In a past clinical study, first generation engineered T cells did not shrink tumors in women with ovarian cancer because the T cells did not persist in the patients. The new second generation technology developed in the current study overcomes the limitations of the first generation approach. Here, second generation T cells shrank tumors; whereas, T cells engineered using first generation technology did not.

The alpha-folate receptor is expressed on the surface of ovarian cancer cells and has a high affinity for folic acid, a vitamin which helps "feed" the cancer cells, and represents an "Achilles' Heel" for cancer researchers to target.

"We anticipate the opening of a genetically modified T cell clinical trial in the next few months for women with recurrent ovarian cancer," says Powell. "Targeting the alpha-folate receptor is an opportunity for widespread clinical application."

Until now, human T cells engineered to express an antibody fragment specific for the alpha-folate receptor protein have shown anti-tumor activity against epithelial cancers in the lab, but not in the clinic due to their inability to persist and home to tumors in the human body. The modified T cells used in this study express an engineered fusion protein – called a chimeric antigen receptor - that combines the specificity of an antibody with the T cell signaling portions from two different proteins that stimulate the immune system to recognize ovarian cancer cells. These added signaling protein pieces give the engineered T cells the extra survival signals they need to do their job.

Two Birds, One Stone T Cells

The double-barreled cells are engineered to multiply, survive, recognize, and kill ovarian tumors. The modified T cells are expanded for two weeks in the lab, and then tested for reactivity by exposing them to human ovarian cancer cells to see if they destroy the cancer cells. Researchers also test for effectiveness by measuring cytokine production by the T cells, a sign of inflammation produced by the engineered T cells when killing cancer cells.

The new second generation engineered cells were successful in many ways. They were resistant to cancer-induced cell death: Fewer new T cells died when exposed to cancer cells, compared to the older technology. The new T cells also multiply better and survive; therefore their numbers increase over time in test-tube experiments and in the mouse model.

A clinical trial using these T cells is pending with George Coukos, MD, Director of the Ovarian Cancer Research Center at Penn and the trial's principal investigator. Penn is the only study site identified to date. Investigators aim to recruit up to 21 patients with advanced recurrent ovarian cancer whose tumors express the alpha-folate receptor.

"This technology represents a promising advancement for the treatment of women with ovarian cancer," Powell says, "But we will continue to work around the clock to improve this approach using other costimulatory portions and antibody-like proteins to make this the most powerful and safe approach for the treatment of the greatest number of women with this horrible disease."

INFORMATION:

Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $4 billion enterprise.

Penn's Perelman School of Medicine is currently ranked #2 in U.S. News & World Report's survey of research-oriented medical schools and among the top 10 schools for primary care. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $507.6 million awarded in the 2010 fiscal year.

The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania -- recognized as one of the nation's top 10 hospitals by U.S. News & World Report; Penn Presbyterian Medical Center; and Pennsylvania Hospital – the nation's first hospital, founded in 1751. Penn Medicine also includes additional patient care facilities and services throughout the Philadelphia region.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2010, Penn Medicine provided $788 million to benefit our community.

END



ELSE PRESS RELEASES FROM THIS DATE:

Penn researchers describe key molecule that keeps immune cell development on track

2011-08-09
PHILADELPHIA – In the latest issue of Nature, researchers at the Perelman School of Medicine at the University of Pennsylvania clarify the role of two proteins key to T-cell development. They found that one well-known protein called Notch passes off much of its role during T-cell maturation to another protein called TCF-1. T cells are required for many aspects of immunity, and understanding how these proteins influence the production of infection-fighting cells could improve treatments for immune-suppressed patients. The research group, led by senior author Avinash Bhandoola, ...

Tracking crime in real time

Tracking crime in real time
2011-08-09
Almost everything we do leaves a digital trace, whether we send an email to a friend or make a purchase online. That includes law-abiding citizens — and criminals. And with digital information multiplying by the second, there are seemingly endless amounts of information for criminal investigators to gather and process. Now Prof. Irad Ben-Gal, Dr. Eugene Kagan and Ph.D. student Aviv Gruber of the Department of Industrial Engineering in Tel Aviv University's Ibi and Aladar Fleischman Faculty of Engineering are using these digital traces to catch criminals and beef up homeland ...

Finding their way: Study shows connection between academic direction and student learning

2011-08-09
MANHATTAN, KAN. -- A Kansas State University professor is helping students improve their confidence and academic performance by creating a map of learning. Candice Shoemaker, professor of horticulture, has spent more than four years looking at students and self-efficacy. Self-efficacy involves student confidence in understanding topics and is often linked with academic motivation, learning and achievement. Shoemaker's published research appeared in a recent issue of HortTechnology. Shoemaker studied self-efficacy by creating a course map for students in the Principles ...

Mosquitoes can't spot a spermless mate

2011-08-09
A female mosquito cannot tell if the male that she has mated with is fertile or 'spermless' and unable to fertilise her eggs, according to a new study from scientists at Imperial College London. The research, published today in the journal Proceedings of the National Academy of Sciences, could help scientists in their mission to prevent the spread of malaria by interfering with the mosquitoes' ability to reproduce. Malaria is a debilitating disease that affects more than 300 million people every year, and kills nearly 800,000 annually. In Africa, a child dies of malaria ...

NASA's NPP satellite completes comprehensive testing

NASAs NPP satellite completes comprehensive testing
2011-08-09
GREENBELT, Md. -- The NASA National Polar-orbiting Operational Environmental Satellite System (NPOESS) Preparatory Project (NPP) has successfully completed its most comprehensive end-to-end compatibility test of the actual satellite and all five scientific instruments at Ball Aerospace & Technologies Corp's production and test facility in Boulder, Colo. During the four-week NPP Compatibility Test 4 (NCT4), all segments of the ground system were assessed including active commanding of the satellite as well as monitoring the flow of both satellite health and safety and ...

Researchers use neutrons to spy on the elusive hydronium ion

2011-08-09
LOS ALAMOS, New Mexico, August 8, 2011—A Los Alamos National Laboratory research team has harnessed neutrons to view for the first time the critical role that an elusive molecule plays in certain biological reactions. The effort could aid in treatment of peptic ulcers or acid reflux disease, or allow for more efficient conversion of woody waste into transportation fuels. In a paper appearing this week in Angewandte Chemie International Edition, Los Alamos researchers join an international team in describing the role played by the elusive hydronium ion in the transfer ...

Education affects Americans' religiosity -- but not how you might think

2011-08-09
It's pretty much a given that the more educated someone becomes, the more likely they are to question their religious beliefs, stop going to church and even abandon their faith entirely. Or is it? A new University of Nebraska-Lincoln study challenges that age-old notion with findings that show education actually has a positive effect on Americans' churchgoing habits, their devotional practices, their emphasis on religion in daily life and their support for religious leaders to weigh in on the issues of the day. The work, to be published in a forthcoming edition of ...

NASA satellites saw Tropical Depression Emily struggle over the weekend

NASA satellites saw Tropical Depression Emily struggle over the weekend
2011-08-09
Former Tropical Storm Emily made a brief comeback this weekend after degenerating over the mountains of Hispaniola late last week, and NASA's Aqua satellite captured an image of Emily just after her "rebirth." At 5 p.m. EDT on Saturday, August 6, Emily became a tropical depression for the second time in her life about 70 miles west-northwest of Great Abaco Island, near 26.9 North and 78.1 West. She was moving to the north at 8 mph and had a minimum central pressure of 1012 millibars. Maximum sustained winds were 30 mph. At 18:25 UTC 2:25 p.m. EDT, the Moderate Resolution ...

Increase in tornado, hurricane damage brings call for more stringent building standards

2011-08-09
CORVALLIS, Ore. – Researchers from a team funded by the National Science Foundation have examined some of last spring's massive tornado damage and conclude in a new report that more intensive engineering design and more rigorous, localized construction and inspection standards are needed to reduce property damage and loss of life. As one of the nation's most destructive tornado seasons in history begins to wane, and hurricane season approaches its peak, experts are working to determine if old, tried-and-true approaches to residential and small building construction are ...

NASA satellites see Tropical Storm Muifa taking up the Yellow Sea

NASA satellites see Tropical Storm Muifa taking up the Yellow Sea
2011-08-09
Tropical Storm Muifa is filling up the Yellow Sea on NASA satellite imagery as it continues moving north today to a landfall in East China's Shandong province. NASA's Aqua satellite captured visible and infrared imagery that shows Muifa's cloud cover stretches across the Yellow Sea, from China to the west to South and North Korea to the east. At 18:25 UTC 2:25 p.m. EDT, the Moderate Resolution Imaging Spectroradiometer (MODIS) instrument on NASA's Aqua satellite captured a visible image of Tropical Storm Muifa moving through the Yellow Sea on August 6 at10:50 p.m. EDT. ...

LAST 30 PRESS RELEASES:

Research quantifies “gap” in carbon removal for first time

Study: ChatGPT displays lower concern for child development “warning signs” than physicians

Study: Childcare is unaffordable for U.S. medical residents

Study: New approach to equitable social care connects pediatric caregivers to resources without screening

Study: Rural children struggle to access hospital services

Study: Longer use of breathing device supports lung growth in preterm infants

Study: Newborn umbilical cord procedure safe for long-term neurodevelopment in children

Study: Eye ultrasounds may assist with detecting brain shunt failure in children

Study: Children with hypertension at higher long-term risk for serious heart conditions

Study: Rotavirus vaccinations in NICU pose minimal risk

Study: Long COVID symptoms in children vary by age

Study: Multicomponent intravenous lipid emulsion improves brain development in preterm infants

PAS 2024: Nemours Children’s Health researchers to present on youth mental health, vaccination, autism and respiratory illness

Lake tsunamis pose significant threat under warming climate

New Nevada experiments will improve monitoring of nuclear explosions

New study challenges one-size-fits-all approach to vitamin D supplementation guidelines

MBL Director Nipam Patel elected to National Academy of Sciences

The future of digital agriculture

Lahar detection system upgraded for mount rainier

NCSA's Bill Gropp elected to AAAS Council

George Mason University receives over $1.1 million to revolutionize Lyme disease testing

NASA selects BAE systems to develop air quality instrument for NOAA

For microscopic organisms, ocean currents act as 'expressway' to deeper depths, study finds

Rice’s Harvey, Ramesh named to National Academy of Sciences

Oil palm plantations are driving massive downstream impact to watershed

Nanotubes, nanoparticles, and antibodies detect tiny amounts of fentanyl

New eco-friendly lubricant additives protect turbine equipment, waterways

Monoclonal Antibodies in Immunodiagnosis and Immunotherapy appoints new Deputy Editor-in-Chief, Andrei Moroz, PhD

Optical pumped magnetometer magnetocardiography as a potential method of therapy monitoring in fulminant myocarditis

Heart failure registries in Asia – what have we learned?

[Press-News.org] Penn study finds more effective approach against 'Achilles' heel' of ovarian cancer